公开(公告)号：US20240269127A1

公开(公告)日：2024-08-15

申请号：US18608261

申请日：2024-03-18

Applicant: Hinova Pharmaceuticals Inc.

Inventor： Xing Wei ,  Tongtao Kuang ,  Jiang Chen ,  Chaowu Ai ,  Xinghai Li

IPC: A61K31/47 ,  A61K9/20 ,  A61K9/28 ,  C07D215/36

CPC classification number: A61K31/47 ,  A61K9/2013 ,  A61K9/2018 ,  A61K9/2054 ,  A61K9/2095 ,  A61K9/2866 ,  C07D215/36

Abstract: This patent document provides a sustained-release formulation comprising 1-40 parts of a quinoline compound, 100-300 parts of a filler, 50-200 parts of a sustained-release material and optionally 0.5-4 parts of a lubricant. Also provided are methods of treating diseases with the sustained-release formulation.